366 related articles for article (PubMed ID: 24467530)
1. Molecular targeted approaches to cancer therapy and prevention using chalcones.
Jandial DD; Blair CA; Zhang S; Krill LS; Zhang YB; Zi X
Curr Cancer Drug Targets; 2014; 14(2):181-200. PubMed ID: 24467530
[TBL] [Abstract][Full Text] [Related]
2. Recent trends of chalcones potentialities as antiproliferative and antiresistance agents.
Winter E; Locatelli C; Di Pietro A; Creczynski-Pasa TB
Anticancer Agents Med Chem; 2015; 15(5):592-604. PubMed ID: 25553434
[TBL] [Abstract][Full Text] [Related]
3. Chalcones as Promising Antitumor Agents by Targeting the p53 Pathway: An Overview and New Insights in Drug-Likeness.
Moreira J; Almeida J; Saraiva L; Cidade H; Pinto M
Molecules; 2021 Jun; 26(12):. PubMed ID: 34205272
[TBL] [Abstract][Full Text] [Related]
4. Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer.
WalyEldeen AA; Sabet S; El-Shorbagy HM; Abdelhamid IA; Ibrahim SA
Chem Biol Interact; 2023 Jan; 369():110297. PubMed ID: 36496109
[TBL] [Abstract][Full Text] [Related]
5. Chalcones derivatives acting as cell cycle blockers: potential anti cancer drugs?
Boumendjel A; Ronot X; Boutonnat J
Curr Drug Targets; 2009 Apr; 10(4):363-71. PubMed ID: 19355861
[TBL] [Abstract][Full Text] [Related]
6. Heterocyclic chalcone analogues as potential anticancer agents.
Sharma V; Kumar V; Kumar P
Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial potential of chalcones and its derivatives against
da Silva L; Donato IA; Gonçalves CAC; Scherf JR; Dos Santos HS; Mori E; Coutinho HDM; da Cunha FAB
3 Biotech; 2023 Jan; 13(1):1. PubMed ID: 36466769
[TBL] [Abstract][Full Text] [Related]
8. Activation of Nrf2 signaling pathway by natural and synthetic chalcones: a therapeutic road map for oxidative stress.
Egbujor MC; Saha S; Buttari B; Profumo E; Saso L
Expert Rev Clin Pharmacol; 2021 Apr; 14(4):465-480. PubMed ID: 33691555
[No Abstract] [Full Text] [Related]
9. Tubulins - the target for anticancer therapy.
Vindya NG; Sharma N; Yadav M; Ethiraj KR
Curr Top Med Chem; 2015; 15(1):73-82. PubMed ID: 25579568
[TBL] [Abstract][Full Text] [Related]
10. Promising anti-inflammatory effects of chalcones via inhibition of cyclooxygenase, prostaglandin E
Ur Rashid H; Xu Y; Ahmad N; Muhammad Y; Wang L
Bioorg Chem; 2019 Jun; 87():335-365. PubMed ID: 30921740
[TBL] [Abstract][Full Text] [Related]
11. Anti-cancer chalcones: Structural and molecular target perspectives.
Mahapatra DK; Bharti SK; Asati V
Eur J Med Chem; 2015 Jun; 98():69-114. PubMed ID: 26005917
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
Gibson MZ; Nguyen MA; Zingales SK
Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
[TBL] [Abstract][Full Text] [Related]
13. Chalcone Derivatives: Role in Anticancer Therapy.
Ouyang Y; Li J; Chen X; Fu X; Sun S; Wu Q
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208562
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic Effect of Flavonoids and Chalcones: An Update.
Mirossay L; Varinská L; Mojžiš J
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29271940
[TBL] [Abstract][Full Text] [Related]
15. Advances in chalcones with anticancer activities.
Karthikeyan C; Moorthy NS; Ramasamy S; Vanam U; Manivannan E; Karunagaran D; Trivedi P
Recent Pat Anticancer Drug Discov; 2015; 10(1):97-115. PubMed ID: 25138130
[TBL] [Abstract][Full Text] [Related]
16. Novel plant-derived target drugs: a step forward from licorice?
Lorusso V; Marech I
Expert Opin Ther Targets; 2013 Apr; 17(4):333-5. PubMed ID: 23425066
[TBL] [Abstract][Full Text] [Related]
17. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
18. Signaling pathways and proteins targeted by antidiabetic chalcones.
Adelusi TI; Du L; Chowdhury A; Xiaoke G; Lu Q; Yin X
Life Sci; 2021 Nov; 284():118982. PubMed ID: 33387581
[TBL] [Abstract][Full Text] [Related]
19. The role of chalcones in suppression of NF-κB-mediated inflammation and cancer.
Yadav VR; Prasad S; Sung B; Aggarwal BB
Int Immunopharmacol; 2011 Mar; 11(3):295-309. PubMed ID: 21184860
[TBL] [Abstract][Full Text] [Related]
20. The Role of Indirubins in Inflammation and Associated Tumorigenesis.
Cheng X; Merz KH
Adv Exp Med Biol; 2016; 929():269-290. PubMed ID: 27771929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
